Agilent Technologies Inc (N:A)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEC
Company Contact
Address: 5301 Stevens Creek Blvd
SANTA CLARA CA 95051
Tel: N/A
Website: https://www.agilent.com
IR: See website
<
Key People
Michael R. Mcmullen
President, Chief Executive Officer, Director
Robert W. Mcmahon
Chief Financial Officer, Senior Vice President
Michael Tang
Senior Vice President, General Counsel, Secretary
Dominique P. Grau
Senior Vice President - Human Resources and Global Communications
Henrik Ancher-Jensen
Senior Vice President - Agilent, President - Order Fulfillment and Supply Chain
Philip Binns
Senior Vice President, Agilent and President of Life Sciences and Applied Markets Group
Padraig Mcdonnell
Senior Vice President, President of Agilent CrossLab
Rodney Gonsalves
Chief Accounting Officer, Vice President, Corporate Controllership
 
Business Overview
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.
Financial Overview
For the three months ended 31 January 2024, Agilent Technologies Inc revenues decreased 6% to $1.66B. Net income decreased 1% to $348M. Revenues reflect Life Sciences and Applied Markets segment decrease of 18% to $846M, United States segment decrease of 8% to $630M, Asia Pacific segment decrease of 7% to $570M. Net income also reflects Life Sciences and Applied Markets segment income decrease of 25% to $236M.
Employees: 17,700 as of Jan 31, 2024
Reporting Currency: U.S. Dollars
Enterprise value: $43,449M as of Jan 31, 2024
Annual revenue (TTM): $6,735M as of Jan 31, 2024
EBITDA (TTM): $1,918M as of Jan 31, 2024
Net annual income (TTM): $1,236M as of Jan 31, 2024
Free cash flow (TTM): $1,382M as of Jan 31, 2024
Net Debt Last Fiscal Year: $807.00M as of Jan 31, 2024
Shares outstanding: 293,055,284 as of Feb 27, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.